These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 9304579)
1. Microdosimetry spectra of the Loma Linda proton beam and relative biological effectiveness comparisons. Coutrakon G; Cortese J; Ghebremedhin A; Hubbard J; Johanning J; Koss P; Maudsley G; Slater CR; Zuccarelli C Med Phys; 1997 Sep; 24(9):1499-506. PubMed ID: 9304579 [TBL] [Abstract][Full Text] [Related]
2. Significance and implementation of RBE variations in proton beam therapy. Paganetti H Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306 [TBL] [Abstract][Full Text] [Related]
3. Apparent absence of a proton beam dose rate effect and possible differences in RBE between Bragg peak and plateau. Matsuura T; Egashira Y; Nishio T; Matsumoto Y; Wada M; Koike S; Furusawa Y; Kohno R; Nishioka S; Kameoka S; Tsuchihara K; Kawashima M; Ogino T Med Phys; 2010 Oct; 37(10):5376-81. PubMed ID: 21089773 [TBL] [Abstract][Full Text] [Related]
4. Microdosimetry spectra and relative biological effectiveness of 15 and 30MeV proton beams. Pan CY; Huang YW; Cheng KH; Chao TC; Tung CJ Appl Radiat Isot; 2015 Mar; 97():101-105. PubMed ID: 25562679 [TBL] [Abstract][Full Text] [Related]
5. Empirical model estimation of relative biological effectiveness for proton beam therapy. Chen Y; Ahmad S Radiat Prot Dosimetry; 2012 Apr; 149(2):116-23. PubMed ID: 21593038 [TBL] [Abstract][Full Text] [Related]
6. Relative biological effectiveness and microdosimetry of a mixed energy field of protons up to 200 MeV. Robertson JB; Eaddy JM; Archambeau JO; Coutrakon GB; Miller DW; Moyers MF; Siebers JV; Slater JM; Dicello JF Adv Space Res; 1994 Oct; 14(10):271-5. PubMed ID: 11539961 [TBL] [Abstract][Full Text] [Related]
7. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure. Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301 [TBL] [Abstract][Full Text] [Related]
9. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay. Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549 [TBL] [Abstract][Full Text] [Related]
11. Physical and biological factors determining the effective proton range. Grün R; Friedrich T; Krämer M; Zink K; Durante M; Engenhart-Cabillic R; Scholz M Med Phys; 2013 Nov; 40(11):111716. PubMed ID: 24320424 [TBL] [Abstract][Full Text] [Related]
12. Monte Carlo simulations of a low energy proton beamline for radiobiological experiments. Dahle TJ; Rykkelid AM; Stokkevåg CH; Mairani A; Görgen A; Edin NJ; Rørvik E; Fjæra LF; Malinen E; Ytre-Hauge KS Acta Oncol; 2017 Jun; 56(6):779-786. PubMed ID: 28464743 [TBL] [Abstract][Full Text] [Related]
13. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam. Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508 [TBL] [Abstract][Full Text] [Related]
14. SOI microdosimetry and modified MKM for evaluation of relative biological effectiveness for a passive proton therapy radiation field. Debrot E; Tran L; Chartier L; Bolst D; Guatelli S; Vandevoorde C; de Kock E; Beukes P; Symons J; Nieto-Camero J; Prokopovich DA; Chiriotti S; Parisi A; De Saint-Hubert M; Vanhavere F; Slabbert J; Rosenfeld AB Phys Med Biol; 2018 Nov; 63(23):235007. PubMed ID: 30468682 [TBL] [Abstract][Full Text] [Related]
15. Characterization of proton pencil beam scanning and passive beam using a high spatial resolution solid-state microdosimeter. Tran LT; Chartier L; Bolst D; Pogossov A; Guatelli S; Petasecca M; Lerch MLF; Prokopovich DA; Reinhard MI; Clasie B; Depauw N; Kooy H; Flanz JB; McNamara A; Paganetti H; Beltran C; Furutani K; Perevertaylo VL; Jackson M; Rosenfeld AB Med Phys; 2017 Nov; 44(11):6085-6095. PubMed ID: 28887837 [TBL] [Abstract][Full Text] [Related]
16. Radiobiological significance of beamline dependent proton energy distributions in a spread-out Bragg peak. Paganetti H; Goitein M Med Phys; 2000 May; 27(5):1119-26. PubMed ID: 10841418 [TBL] [Abstract][Full Text] [Related]
17. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment. Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743 [TBL] [Abstract][Full Text] [Related]
18. Microdosimetry study of THOR BNCT beam using tissue equivalent proportional counter. Hsu FY; Hsiao HW; Tung CJ; Liu HM; Chou FI Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S175-8. PubMed ID: 19447042 [TBL] [Abstract][Full Text] [Related]
19. First experimental measurements of 2D microdosimetry maps in proton therapy. Guardiola C; Bachiller-Perea D; Kole EMM; Fleta C; Quirion D; De Marzi L; Gómez F Med Phys; 2023 Jan; 50(1):570-581. PubMed ID: 36066129 [TBL] [Abstract][Full Text] [Related]
20. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital. Wouters BG; Skarsgard LD; Gerweck LE; Carabe-Fernandez A; Wong M; Durand RE; Nielson D; Bussiere MR; Wagner M; Biggs P; Paganetti H; Suit HD Radiat Res; 2015 Feb; 183(2):174-87. PubMed ID: 25587741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]